Journée Scientifique 2020

29th ARTP Annual Meeting - 18 November 2020
PROSTATE BENIGN HYPERPLASIA AND CANCER: FROM BASIC RESEARCH TO CLINICAL PRACTICE

 

Palais des Congrès de Paris - 2 place de la Porte Maillot - 75017 Paris

Téléchargez le plan d'accès au Palais des Congrès

Téléchargez le programme 2020 sous format PDF

8:15 a.m.
Registration at the ARTP Registration Desk (3rd floor)

8:55 a.m.
Welcome by Pr Alexandre de la Taille, ARTP President

9:00 a.m.
Session I : ESUR 2019 & ARTP 2018 Laureates
Chairs : Jocelyn Céraline, Laurent Morel

Speakers : 
Pr Laurent Guy (Centre Jean Perrin, Clermont-Ferrand)
'Evaluation du volume tumoral prostatique après un traitement inhibiteur de la déméthylase d'histone JMJD3'
Dr Gilles Marodon (CIMI, Inserm U1135, Paris)
'La molécule HVEM comme nouvelle cible pour l'immunothérapie du cancer de la prostate' 
Dr Silvère Baron (GredD, CNRS UMR6293, Inserm U1103, Clermont-Ferrand)
'Développement d'une technique de transparisation des tissus pour l'étude de l'impact de traitements d'agents chimiothérapeutiques'
Lisa Moris (Faculty of Medicine, Leuven, Belgium)
'Genomic analysis of localized prostate cancer identifies AZIN1 as a driver of metastatic progression'

9:55 a.m.
Coffee break
 

10:15 a.m.
Session II : Microenvironment in Prostate Cancer
Chair : Frédéric Bost, Stéphane Terry

Speakers : 
Dr Andrea Alimonti (Institute of Oncology Research, Bellinzona, Switzerland)
'Immune cells and prostate cancer'
Dr Ewa Snaar-Jagalska (Leiden University, Leiden, The Netherlands) 
'Microenvironment elevates ENT and CSC-like phenotype of engrafted prostate cancer cells'
Dr Claire Magnon (CEA, Paris)
'Nerve contribution to prostate cancer progression' 

11:55 a.m.
Special COVID-19 talk

Dr Pierre-Jean Lamy (Institut de Cancérologie Privé, Montpellier)
'Role of serine protease TMPRSS2 in SARC-CoV2 infection'

12:05 p.m.
Lunch
 
 

1:45 p.m.
Session III : Novel techniques in Urology
Chairs : Arnauld Villers, Alexandre de la Taille

Speakers : 
Pr Nicolas Barry Delongchamps
 (Hôpital Cochin, Paris)
'News concepts and techniques for benign prostatic obstruction relief'
Pr Olivier Rouvière (Hospices Civils de Lyon, Lyon) 
'A peel in the future: Artificial intelligence and prostate cancer imaging'

2:45 p.m.
Coffee break

 

3:00 p.m.
Session IV : Cell plasticity in Prostate cancer Clinical Practice
Moderators : Claire Le Magnen, Vincent Goffin

Speakers : 
Michael Shen
 (Irving Cancer Research Center, New York, USA))
'Cell of origin and lineage plasticity in prostate cancer'
Hamid Abis (Dana-Farber Cancer Institute, Boston, USA)
'Luminal B subtype as a predictive bioimarker of docetaxel benefit for newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC): A correlative study of E3805 CHAARTED' 
 

4:00 p.m.
Session V : Poster Session (
ANNULE)

5:00 p.m.
Session VI : 2019 ARTP Poster Prize Laureates (
ANNULE)

Speakers : 
Charlotte Dubois
 (Inserm U1102, Lille)
'Apoptosis mediated by mitochondrial Ca2+ overload requires inhibition of autophagy revealing a widespread vulnerability of cancer cells'
David Estève (IPBS, CNRS UMR5089, Toulouse)
'The adipose tissue that surrounds the prostate gland exhibits traits of hypoxic state that could contribute to its role in prostate cancer progression' 
Clément Paris (CRCM, Marseille)
'Lipid antisense oligonucleotides nanoparticle: nanoplatform agent for the treatment of castration-resistant prostate cancer''

5:25 p.m.
Présentation de l'ANAMACaP (ANNULE)
Association de patients
Roland Muntz, Président

5:40 p.m.
ARTP General Assembly/Assemblée Générale (ANNULE)
Pr Alexandre de la Taille, ARTP President
Dr Olivier Cuvillier, ARTP Treasurer
Distribution Prix Poster 2020

6:00 p.m.
End of the meeting

 

 

Sponsors de la Journée Scientifique  2020

Association Française d'Urologie, Pierre Fabre Médicament, Astellas Pharma, Janssen-Cilag, Astra-Zeneca, Bayer, Ipsen, Ferring, Bouchara-Recordati